BRIEF-Amgen and UCB submit biologics license application for romosozumab to the FDA
July 22, 2016 at 01:05 AM EDT
* Amgen and UCB submit biologics license application for romosozumab to the FDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.